We analyzed the publicly available Gene Expression Omnibus database (GEO: GSE89632) and found that the expression of hepatic GSDMD was significantly increased in patients with NASH compared to healthy individuals (Fig. 1A). Here, GSDMD is linked to metabolic dysfunction-associated steatohepatitis.